BridgeMD
New treatment option for Pancreatic Cancer
Official title PGHD-AI Intelligent Model for the Nutritional Assessment and Intervention of Patients After Radical Surgery for Pancreatic Cancer.
ClinicalTrials.gov ID: NCT07167264
What this study is testing
- What it's testing
- This study will collect patient PRO (physical strength, pain, defecation, appetite, weight, etc.) data through the APP, use corpus collection cards, facial photography and other technologies to collect PGHD characteristic phenotypes, and then combine artificial intelligence technology to train and cultivate agents (agents) to carry out joint offline routine follow-up of patients after radical pancreatic cancer resection to evaluate the feasibility of nutritional risk assessment intervention. Thus, the feasibility of artificial intelligence prediction of health status is verified, and an efficient follow-up tool and nutritional support evaluation plan are provided for the management of pancreatic cancer patients throughout the course of the disease, so as to improve the treatment prognosis and quality of life of pancreatic cancer patients.
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 to 80
You may be able to join if
- Age: 18-80 years old, and voluntarily signed the informed consent form to participate in the study;
- Meet the clinical and pathological diagnostic criteria for pancreatic cancer (ICD-10:C25);
- After radical surgery, fully recovered from surgery at randomization;
- ECOG PS score 0-1 ;
- Have objective conditions to complete follow-up and examination during the study process.
You likely can't join if
- Patients or their families are willing to use the APP;
- Current history or past history of metastatic or locally recurrent pancreatic cancer;
- Combined with other serious organ dysfunctions (such as severe liver and kidney insufficiency, heart failure, etc.);
- Women who are currently pregnant or lactating;
- History of other tumor diseases in the past;
- Other conditions that the study deems unsuitable for participation in the study, including but not limited to: patients with serious or...
The study team makes the final eligibility decision.
Where it's taking place
- Shanghai, Shanghai Municipality, China
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years to 80 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Shanghai, Shanghai Municipality, China. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.